Benign Prostatic Hyperplasia (BPH)
DESCRIPTION
This non-infectious, non-malignant enlargement of the prostate
gland occurs in 50 to 60% of men, ages 40 to 59. An increase
in prostatic concentrations of potent androgen, a derivative
of testosterone, is most likely the cause. Other hormone
levels are also elevated, including prolactin, oestradiol,
and follicle-stimulating hormone.
The enlargement of the
prostate may lead to urethra obstruction. Symptoms of BPH
include bladder outlet obstruction (hesitancy, increased
urinary frequency, waking at night to urinate, etc.); and
an enlarged, non-tender prostate gland.
HERBS
Panax Ginseng (4)
Nettle (5)
Saw Palmetto (6)
NUTRITIONAL
SUPPLIMENTS
Bee Pollen
Copper
Evening Primrose Oil (2)
Flax Seed Oil (2)
Glutamic Acid (1)
Zinc (3)
REFERENCES
1. Damrau F. Benign prostatic hypertrophy: amino acid therapy
for symptomatic relief. J Am Geriatr Soc 1962;10:426-30.
2. Hart JP and Cooper WL. Vitamin F in the treatment of
Prostatic Hyperplasia. Lee Foundation for Nutritional Research,
Report #1. Milwaukee, Wisconsin:1941.
3. Fahim M, Fahim Z, and Harman J. Zinc treatment for the
reduction of hyperplasia of the prostate. Fed Proc 1976;
35:361.
4. Saito Y. Diagnosis and treatment of chronic prostatitis
with special reference to experience with Cernilton. Clin
Exp Med 1967; 44:387-93.
5. ESCOP monographs. Fascicule 2: Urticae radix. Exeter,
UK: European Scientific Cooperative on Phytotherapy, 1997:
4.
6. Carraro J, et al. Comparison of phytotherapy (Permixon)
with finasteride in the treatment of benign prostate hyperplasia:
a randomized international study of 1,098 patients. Prostate
29(4): 231-240, 1996.
